DE69633864D1 - Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität - Google Patents

Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität

Info

Publication number
DE69633864D1
DE69633864D1 DE69633864T DE69633864T DE69633864D1 DE 69633864 D1 DE69633864 D1 DE 69633864D1 DE 69633864 T DE69633864 T DE 69633864T DE 69633864 T DE69633864 T DE 69633864T DE 69633864 D1 DE69633864 D1 DE 69633864D1
Authority
DE
Germany
Prior art keywords
subtilin
chimera
nisin
biological activity
terminal portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69633864T
Other languages
English (en)
Other versions
DE69633864T2 (de
Inventor
Norman Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of DE69633864D1 publication Critical patent/DE69633864D1/de
Application granted granted Critical
Publication of DE69633864T2 publication Critical patent/DE69633864T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/267—Microbial proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3571—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69633864T 1995-09-28 1996-09-30 Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität Expired - Lifetime DE69633864T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US535494 1995-09-28
US08/535,494 US5861275A (en) 1995-09-28 1995-09-28 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same
PCT/US1996/015160 WO1997011713A1 (en) 1995-09-28 1996-09-30 Lantibiotic mutants and chimeras of enhanced stability and activity

Publications (2)

Publication Number Publication Date
DE69633864D1 true DE69633864D1 (de) 2004-12-23
DE69633864T2 DE69633864T2 (de) 2005-11-03

Family

ID=24134482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633864T Expired - Lifetime DE69633864T2 (de) 1995-09-28 1996-09-30 Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität

Country Status (11)

Country Link
US (2) US5861275A (de)
EP (1) EP0852502B1 (de)
JP (1) JP2001517923A (de)
KR (1) KR19990063817A (de)
AT (1) ATE282421T1 (de)
AU (1) AU720529B2 (de)
CA (1) CA2230933A1 (de)
DE (1) DE69633864T2 (de)
NZ (1) NZ319425A (de)
WO (1) WO1997011713A1 (de)
ZA (1) ZA968160B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6953683B2 (en) * 1997-07-18 2005-10-11 University Of Maryland Compositions and methods of inhibiting bacterial spore germination
AU8484798A (en) 1997-07-18 1999-02-10 University Of Maryland Sublancin lantibiotic produced by (bacillus subtilis) 168
CA2356955A1 (en) * 1998-12-24 2000-07-06 University Of Maryland Stable subtilin and methods of manufacture
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
US7033766B2 (en) * 2000-06-29 2006-04-25 University Of Maryland Office Of Technology Commercialization Construction and screening of lantibody display libraries
US6759205B2 (en) 2000-06-29 2004-07-06 University Of Maryland Construction of a strain of Bacillus subtilis 168 that displays the sublancin lantibiotic on the surface of the cell
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
US7199230B2 (en) * 2002-10-10 2007-04-03 Molichem Medicines, Inc. Nucleic acids encoding duramycin
ATE487488T1 (de) * 2006-03-09 2010-11-15 Cambridge Entpr Ltd Neuartige antibiotische zusammensetzungen
IE20080365A1 (en) * 2008-05-09 2010-03-16 Univ College Cork Nat Univ Ie Nisin derivatives and the use thereof
EP2338904A1 (de) * 2009-12-22 2011-06-29 TEAGASC, The Agriculture and Food Development Authority Nisinderivate und Verwendungen dafür

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597972A (en) * 1983-06-10 1986-07-01 Aplin & Barrett, Ltd. Nisin as an antibotulinal agent for food products
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
DE69232930T2 (de) * 1991-04-11 2003-12-11 Stichting Nl I Voor Zuivelonde Nisin a aehnliche lantibiotika, diese produzierende milchsaeurebakterien und deren herstellung
GB9423404D0 (en) * 1994-11-19 1995-01-11 Biotech & Biolog Scien Res Production of nisin

Also Published As

Publication number Publication date
JP2001517923A (ja) 2001-10-09
NZ319425A (en) 1998-12-23
AU720529B2 (en) 2000-06-01
US5861275A (en) 1999-01-19
KR19990063817A (ko) 1999-07-26
EP0852502A1 (de) 1998-07-15
WO1997011713A1 (en) 1997-04-03
US6153405A (en) 2000-11-28
ZA968160B (en) 1997-05-02
EP0852502A4 (de) 2001-07-11
AU7164196A (en) 1997-04-17
EP0852502B1 (de) 2004-11-17
CA2230933A1 (en) 1997-04-03
ATE282421T1 (de) 2004-12-15
DE69633864T2 (de) 2005-11-03

Similar Documents

Publication Publication Date Title
DE69633864D1 (de) Lantibiotikmutanten und chimeren mit erhöhter stabilität und aktivität
IL173253A0 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
MY119617A (en) 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
DK0535060T3 (da) Antifungisk polypeptid samt fremgangsmåde til dets fremstilling
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
DK0482013T3 (da) Ikke-glycolyserede humant interleukin-3 analoge proteiner
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE226252T1 (de) Subtilinvarianten mit erhöhter stabilität und aktivität
WO1991016434A3 (en) Bacillus thuringiensis cryif and cryix genes and proteins toxic to lepidopteran insects
GR3019246T3 (en) Active ingredient containing shaped bodies of thermoplastic elastomeric polyether-blockamides, process for their preparation and their use for pest control
DE3667469D1 (de) Basische monocarboxylamid-derivate des actagardines mit antibiotischer wirkung.
WO2019219903A3 (en) Mutant lipase and use thereof
AU669149B2 (en) Expression signal-peptide-free staphylokinases
BRPI0107708A8 (pt) Vetor de expressão e secreção para interferon alfa humano e processo para produzir interferon alfa humano empregando o mesmo
AU3674889A (en) Peptide molecules with activity against gram positive microorganisms
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
DE69619530D1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
ATE346941T1 (de) Protein-disulfidisomerase-gen eines methylotrophen hefestammes
PT1289545E (pt) Vacina sint?tica para o controle de carrapatos
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
ES2009599A6 (es) Un metodo para producir la toxina p-2 de bacillus thuringiensis.
GB846960A (en) Improvements in or relating to viners
DK0382268T3 (da) Aminocarboxylsyrederivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition